These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29730946)

  • 81. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Common gastrointestinal symptoms: risks of long-term proton pump inhibitor therapy.
    Fashner J; Gitu AC
    FP Essent; 2013 Oct; 413():29-39. PubMed ID: 24124705
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Proton pump inhibitor side effects and drug interactions: much ado about nothing?
    Madanick RD
    Cleve Clin J Med; 2011 Jan; 78(1):39-49. PubMed ID: 21199906
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 85. PPI therapy: when to worry about fracture risk.
    Heidelbaugh JJ
    J Fam Pract; 2011 May; 60(5):255-60. PubMed ID: 21544271
    [No Abstract]   [Full Text] [Related]  

  • 86. An update on the importance of monitoring serum magnesium in advanced disease patients.
    Centeno C; López Saca JM
    Curr Opin Support Palliat Care; 2013 Dec; 7(4):396-405. PubMed ID: 24126921
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Hypomagnesemia and proton pump inhibitors].
    Fumeaux C; Schmidtko J; Meier P
    Rev Med Suisse; 2012 Apr; 8(336):806-10. PubMed ID: 22574415
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
    Mackay JD; Bladon PT
    QJM; 2010 Jun; 103(6):387-95. PubMed ID: 20378675
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
    Semb S; Helgstrand F; Hjørne F; Bytzer P
    World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Proton pump inhibitors and risk of hypomagnesemia.
    Pasina L; Zanotta D; Puricelli S; Djignefa DC; Bonoldi G
    Eur J Intern Med; 2015 Sep; 26(7):e25-6. PubMed ID: 26165831
    [No Abstract]   [Full Text] [Related]  

  • 91. Oculogyric crisis in proton pump inhibitor-associated hypomagnesemia.
    Civardi C; Collini A; Geda C
    Parkinsonism Relat Disord; 2020 Mar; 72():80-81. PubMed ID: 32146379
    [No Abstract]   [Full Text] [Related]  

  • 92. Defining Appropriate Use of Proton-Pump Inhibitors Among Medical Inpatients.
    Pappas M; Jolly S; Vijan S
    J Gen Intern Med; 2016 Apr; 31(4):364-71. PubMed ID: 26553337
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia.
    Chrysant SG; Chrysant GS
    Expert Opin Drug Saf; 2020 Jan; 19(1):59-67. PubMed ID: 31795777
    [No Abstract]   [Full Text] [Related]  

  • 94. Hypomagnesaemia due to use of proton pump inhibitors--a review.
    Kuipers MT; Thang HD; Arntzenius AB
    Neth J Med; 2009 May; 67(5):169-72. PubMed ID: 19581665
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Proton pump inhibitors: fractures (continued). Beware long-term use.
    Prescrire Int; 2011 Oct; 20(120):241. PubMed ID: 21970088
    [No Abstract]   [Full Text] [Related]  

  • 96. Side effects of long-term use of proton pump inhibitors: practical considerations.
    Castellana C; Pecere S; Furnari M; Telese A; Matteo MV; Haidry R; Eusebi LH
    Pol Arch Intern Med; 2021 Jun; 131(6):541-549. PubMed ID: 33982542
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Toxicity of long-term use of proton pump inhibitors in children.
    De Bruyne P; Ito S
    Arch Dis Child; 2018 Jan; 103(1):78-82. PubMed ID: 29237614
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Proton pump inhibitors and cancers: A hazardous association?].
    Raoul JL; Edeline J; Gilabert M; Senellart H; Frenel JS
    Bull Cancer; 2020 Apr; 107(4):458-464. PubMed ID: 32057465
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.
    Fisher L; Fisher A
    Clin Drug Investig; 2017 Jul; 37(7):587-624. PubMed ID: 28361440
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Response to "Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?".
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2014 Mar; 48(3):432. PubMed ID: 24586075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.